ArticleCurrent microbiology2024
Nature-Inspired Antimicrobial Agents: Cinnamon-Derived Copper Oxide Nanoparticles for Effective Aspergillus Niger Control.
Article in Current microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Zinc oxide/copper ferrite ferrofluids derived from natural resources for antifungal applications.Discover nano · 2026Article
- Potent antimicrobial and antibiofilm activity of citric acid coated magnetite nanoparticles for leather preservation.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The emergence of resistant bacterial and fungal strains poses significant challenges in various industrial processes including food, medicines, and leather industry. It necessitates the development of novel and effective antimicrobial agents. In the present work, we have developed an ecofriendly and sustainable approach to synthesize silver-doped copper oxide nanoparticles by using cinnamon bark extract (C-CuO/Ag). The nanoparticles were characterized via UV-visible spectroscopy at 190-800 nm, FT-IR, SEM-EDAX, XRD, and further subjected to determine antimicrobial potential, minimum inhibitory concentration (MIC), and anti-biofilm potential against both bacterial and fungal species. UV-visible spectrum showed maximum absorption at 210 nm in ultraviolet range and 419 nm in visible range. Various strong and weak peaks were obtained in FT-IR spectra, which defined the presence of corresponding functional groups in C-CuO/Ag nanoparticles. SEM analysis revealed the tightly packed confirmation, while EDS confirmed the elemental analysis of C-CuO/Ag nanoparticles. XRD spectrum of C-CuO/Ag nanoparticles showed strong diffraction peaks at 2Ө of 31.92˚, 35.67˚, and 48.51˚, which confined with the plane indices of (-110), (111), and (- 202), respectively, while weak diffraction peaks at 2Ө of 56.31˚, 58.9˚, and 77.4˚, which leads to the crystal planes of (202), (- 220), and (311), respectively. Antimicrobial assays showed clear zones of inhibition against microbial strains as maximum inhibition diameter was observed against Aspergillus niger (31.5 ± 0.7 mm) followed by Escherichia coli (30.1 ± 0.3 mm) and Staphylococcus aureus (29.5 ± 0.7 mm). These findings provide support clear evidence that CuO nanoparticles can serve as potent antibacterial and antifungal compounds against highly resistive and pathogenic microbial strains.
Indexed as
Identifiers
39609279What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.